Frank Salisbury

Frank Salisbury has a diverse and extensive work experience in the pharmaceutical industry. Frank has held various leadership roles in multiple companies, including PureTech Health, Genentech, and Sage Therapeutics. Notably, they served as the Vice President of Marketing at Sage Therapeutics, where they led the build of a marketing team and played a key role in the launch of ZULRESSO, the first FDA-approved treatment for Postpartum Depression. Frank also has experience in sales, having served as the National Sales Director at Genentech. Additionally, they have held roles in business development, strategic planning, and consulting, demonstrating their versatility in the industry.

Frank Salisbury's education history includes an MBA degree from Stanford University Graduate School of Business, which they completed from 2000 to 2002. Prior to that, in 1996 to 1997, they were a Fulbright Scholar in Cologne, Germany, focusing on Public Health Policy. Frank also obtained a Bachelor's degree in International Relations from Stanford University, where they studied from 1992 to 1996.